NCT03620890View on ClinicalTrials.gov

Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

July 29, 2020

Study Completion Date

July 29, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Neutral Protamine Hagedorn (NPH)

NPH will peak between 4-12 hours after injection with a duration of action around 14 hours

DRUG

Detemir insulin

Detemir is characterized by a gentle rise and fall with a longer duration of action (18-20 hours)

Trial Locations (1)

77030

University of Texas Health Science Center of Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy | Biotech Hunter | Biotech Hunter